Pharma

Healthcare

Merck Cautiously Enters GLP-1 Fray Via Licensing Deal With Chinese Drugmaker

Photo by Coolcaesar via CC BY-SA 4.0

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals’ dominance in the GLP-1 space.

2 min read

Photo by Andrew Hecht via CC BY 2.0

Healthcare

Novartis Will Pay Up to $1.1 Billion for California Gene Therapy Startup

Novartis is banking on the startup’s promising treatment candidates for neuromuscular diseases, many of which are genetic in nature.

1 min read
Photo via Novo Nordisk

Healthcare

Novo Nordisk’s Doing Brilliantly, Just Not Brilliantly Enough

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.

1 min read
Photo by Veronique D via iStock

Healthcare

Pharmapalooza: Earnings Highlight Highs and Lows of Cutthroat Sector

It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.

2 min read

Healthcare

Study Suggests Weight-Loss Drugs Like Ozempic May Help Alcoholism, Opioid Addiction

Photo by Chemist4U via CC BY-SA 2.0

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.

1 min read

Healthcare

Eli Lilly’s Weight-Loss Drug Finally Off FDA Shortage List

Photo by Jetcityimage via iStock

The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.

1 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.